Gene therapy for diabetes mellitus;Genová terapie v léčbě diabetes mellitus

Casopis Lekaru Ceskych

Volumn 142, Issue 9, 2003, Pages 523-527

  Saudek, František ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Diabetes mellitus; Gene therapy; Pancreatic islets; Stem cells; Transplantation

Indexed keywords

ALLOANTIGEN; CYTOKINE; DNA FRAGMENT; INSULIN; LIGAND;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; DNA MODIFICATION; DONOR; EMBRYO CELL; GENE MUTATION; GENE THERAPY; GRAFT REJECTION; HEREDITY; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KNOCKOUT GENE; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PATHOGENESIS; REVIEW; STEM CELL; T LYMPHOCYTE; VACCINATION; XENOTRANSPLANTATION;

DIABETES MELLITUS; GENE THERAPY; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; TISSUE ENGINEERING;

EID: 0141459604     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Benhamou, P. Y., Moriscot, C., Richard, M. J. et al.: Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia, 41, 1998, S. 1093-1100.
2. Buhler, L., Friedman, T., Iacomini, J., Cooper, D. K.: Xenotransplantation-state of the art-update 1999. Front. Biosci., 4, 1999, s. D416-D432.
3. Diamond, L. E., Quinn, C. M., Martin, M. J. et al.: A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation, 2001, 71, s. 132-142.
4. Efrat, S., Fleischer, N.: Engineering of the pancreatic b-cell. In: LeRoith, D., Taylor, S. I., Olefsky, J. M. (Eds): Diabetes mellitus. Lippincott-Raven publishers, Philadelphia 1996, s. 438-444.
5. Fajans, S. S., Bell, G. I., Polonsky, K. S.: Molecular mechanisms and clinical pathofphysiology of maturity-onsiat diabetes of the young. N. Engl. J. Med., 2001, 345, s. 971-980.
6. Farivar, R. S., Chen, R. H., Adams, D. H.: Xenotransplantation and the endothelium. Graft, 4, 2001, s. 355-364.
7. Ferber, S., Halkin, A., Cohen, H. et al.: Pancreatic and duodena momeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Mar. Med., 6, 2000, s. 568-572.
8. Flotte, T., Agarwal, A., Wang, J. et al: Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors. Diabetes, 50, 2001, s. 515-520.
9. Garcia-Ocana, A., Takane, K. K., Reddy, V. T. et al.: Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplan performacne and reduces beta cell death. J. Biol. Chem., 278, 2003, s. 343-351.
10. Giannoukakis, N., Rudert, W. A., Ghivizzani, S. C. et al.: Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. Diabetes, 48, 1999, s. 1730-1736.
11. Hašková, V., Hrubešová, M.: Part played by deoxyribonucleic acid in transplantation immunity, Nature, 182, 1958, s. 61-62,
12. Heymsfield, S. B., Greenberg, A. S., Fujioka, K. et al.: Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA, 282, 1999, s. 1568-1575.
13. Cheung, A. T., Dayanandan, B., Lewis, J. T. et al.: Glucose-dependent insulin release from genetically engineered K cells. Science, 290, 2000, s. 1959-1562.
14. Isner, J. M., Pieczek, A., Schainfeld, R. et al.: Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet, 348, 1996, s. 370-374.
15. Korbutt, G. S., Elliot, J. F., Rajotte, R. V.: Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term survival without systemic immunosuppression. Diabetes, 46, 1997, s. 317-322.
16. Lau, H. T., Yu, M., Fontana, A., Stoeckert, C. J. Jr.: Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science, 273, 1996, s. 109-112.
17. Lumelsky, N., Blondel, O., Laeng,P. et al.: Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science, 292, 2001, s. 1389-1394.
18. Medawar, P. B.: Part played by deoxyribonucleic acid in transplantation immunity. Nature, 182, 1958, s. 62.
19. Milo-Landesman, D., Surana, M., Berkowich, I. et al.: Correction of hyperglycemia in diabetic mice transplanted with reversibly immoratlized pancreatic β-cells controlled by the tet-on regulatory systém. Cell Transplantation, 10, 2001, s. C45-C50.
20. Moritani, M., Yoshimoto, K., Wong, S. F. et al.: Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1. J. Clin. Invest, 102, 1998, s. 499-506.
21. Mueller, R., Krahl, T., Sarvetnick, N.: Pancreatic expression of interleukin-4 abrogares insulitin and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med., 189, 1996, s. 1093-1099.
22. Newgard, C. B.: Cellular engineering and gene therapy strategies for insulin replacement in diabetes. Diabetes, 43, 1994, s. 341-350.
23. Peck, A. B., Chaudhari, M., Cornelius, J. G., Ramiya, V.: Pancreatic stem cells: building blocks for a better surrogate to treat type 1 diabetes. Ann. Med., 33, 2001, s. 186-192.
24. Phelps, C. J., Koike, C., Vaught, T. D. et al.: Production of alpha 1,3-galactosyltransferase-deficient pigs. Science, 299, 2003, s. 411-414.
25. Quintana, F. J., Carmi, P., Cohen, I. R.: DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabaetes. J. Immunol., 15, 2002, s. 6030-6035.
26. Rabinovitch, A., Suarez-Pinzon, W., Strynadka, K. et al.: Diabetes, 48, 1999, s. 1223-1229.
27. Rafaeloff, R., Pirrenger, G. L., Barlow, S. W. et al.: Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J. clin. Invest., 99, 1997, s. 2100-2109.
28. Ramiya, V. K., Maraist, M., Arfors, K. E. et al.: Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nature Medicine, 6, 2000, s. 278-282.
29. Raz, I., Elias, D., Vvron, A. et al.: β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II tral. The Lancet, 358, 2001, s. 1749-1753.
30. Saudek, F.: Léčba diabetu transplantací. Maxdorf, Praha 2003 (v tisku).
31. Shapiro, A. M. J., Lakey, J. R. T., Ryan, E. A. et al.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med., 343, 2000, s. 230-238.
32. Schratzberger, P., Schratzberger, G., Silver, M. et al.: Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy, Nat. Med., 6, 2000, s. 405-413.
33. Soria, B., Skoudy, A., Martin, F.: From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. Diabetologia, 44, 2001, s. 407-415.
34. Vasir, B., Jonas, J. C., Steil, G. M. et al.: Gene expression of VEGF and its receptors Flk-1/KDR and Flt-1 in cultured and transplanted rat islets. Transplantation, 15, 2001, s. 924-935.
35. Zhou, Y. T., Wang, Z. W., Higa, M. et al.: Reversing adipocyte differentiation: implications for treatment of obesity. Proc. Natl. Acad. Sci. USA, 96, 1999, s. 2391-2395.
36. Zierath, J. R., Tsao, T. S., Stenvit, A. E. et al.: Restoration of hypoxia-stimulated glucose uptake in GLUT4-deficient muscles by muscle-specific GLUT4 transgenic complementation. J. Biol. Chem., 273, 1998, s. 20910-20915.